ARCHIVES

Urgent FDA Action Turns Power Morcellation Into Rarely Used Gynecological Procedure

This article is from The Cancer Letter archive.

Vol. 40 No. Nov 26 special report | November 26, 2014

Download PDF Visit The Full Archive

Related Articles

Xeloda + Oxaliplatin Compares To FOLFOX-4 In First Line

January 30, 2009

Senate Kills Construction Reprograming Plan; NCI To Seek Limit On Future Grant Applications

March 18, 1977

BRMP Proposals for Thymosins Development

November 30, 1979

FDA Proposes New Nonclinical Lab Regs

November 26, 1976

Clearinghouse Finds Insecticide, Hair Dye Are Carcinogens

December 1, 1978

Allegations Reflect Misunderstanding, Pan Data Says

August 4, 1989